Nextech Invest Ltd.
Zurich, V8 · CIK 1595430 · 13F filing filed 2026-08-14
Exempt reporting adviser since 2022 · other (specify)
- Private funds5 · $2.0bn gross assets
- Form ADV · 2026-03-27SEC adviser record
- Kindprivate equity
- Others nearbyBoston, MA, Zürich, San Francisco, CA
- FamilyNextech Invest Ltd. · 3 related pages
As an employer
- Offices in1 country
- Private fundsprivate equity 5
$2.1bn
reported value
+48.3% vs Q1 2026
15positions
98.0%in top 10
2 new
3 added
1 reduced
4 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| REVOLUTION MEDICINES INC RVMD | $1.4bn67.55% | Unchanged |
| PARABILIS MEDICINES INC PBLS | $127.6m6.06% | New |
| RELAY THERAPEUTICS INC RLAY | $126.8m6.02% | Added +1.2m |
| TYRA BIOSCIENCES INC TYRA | $113.5m5.39% | Reduced -502.3k |
| ALUMIS INC ALMS | $99.6m4.73% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $77.6m3.68% | Unchanged |
| KYMERA THERAPEUTICS INC KYMR | $32.0m1.52% | Unchanged |
| ZYMEWORKS INC ZYME | $29.1m1.38% | Unchanged |
| MONTE ROSA THERAPEUTICS INC GLUE | $18.4m0.87% | Added +456.9k |
| ARVINAS INC ARVN | $17.1m0.81% | Added +583.3k |
| CYTOMX THERAPEUTICS INC CTMX | $16.7m0.79% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $10.5m0.50% | Unchanged |
| CORVUS PHARMACEUTICALS INC CRVS | $6.7m0.32% | Unchanged |
| CONTEXT THERAPEUTICS INC CNTX | $4.1m0.20% | Unchanged |
| ENGENE THERAPEUTICS INC ENGN | $4.0m0.19% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| TANGO THERAPEUTICS INC TNGX | $152.0m7.3m shares |
| CULLINAN THERAPEUTICS INC CGEM | $16.2m1.1m shares |
| ENGENE HOLDINGS INC | $15.8m2.3m shares |
| ARS PHARMACEUTICALS INC SPRY | $4.9m610.7k shares |